The TB population was used to compare simulations with clinical data provided by Dheda et al.17For both midazolam (CYP 3A4/5 substrate) and isoniazid (NAT‐2 substrate), PK differences were simulated for the SA‐TB population in comparison to the European Caucasian population (Figure 6). The gene discussed is NAT2; the disease is tuberculosis.